GCC raises $3.6 billion from 23 IPOs in H1 2024 as healthcare operators weigh listing windows

Gulf capital markets raised $3.6 billion from 23 initial public offerings in the first half of 2024, according to a report from Economy Middle East. The GCC now ranks as the most active IPO corridor outside the United States and India by deal count.

For healthcare operators across the UAE, public market appetite for Gulf assets remains strong, and the sector's consolidation wave is producing companies large enough to list.

Where the money went

The Saudi Exchange (Tadawul) and the Abu Dhabi Securities Exchange (ADX) captured the bulk of listing activity. Saudi Arabia's parallel market, Nomu, continued to attract mid-cap issuers, while Dubai Financial Market drew smaller consumer and services listings.

Healthcare was not the dominant sector in H1 2024 listings. Energy, financial services, and consumer retail led volume. But the pipeline points in a different direction. Pure Health, the Abu Dhabi-based hospital group controlled by ADQ subsidiary Multiply Group, has been expanding through acquisitions at a pace consistent with pre-listing positioning. The group operates more than 25 hospitals and over 100 clinics across the UAE and has signaled international expansion into Egypt and Saudi Arabia.

Burjeel Holdings, which listed on the ADX in October 2022 at a valuation of AED 11.8 billion, remains the benchmark for healthcare IPOs in the region. Its post-listing performance (revenue growth of 14% year-on-year through 2023) demonstrated that public investors will pay for UAE healthcare assets with strong regulatory moats and payer diversification.

What this means for UAE healthcare operators

The IPO window matters for four groups in the UAE healthcare ecosystem.

• Large hospital groups evaluating whether to list or accept private equity buyouts now have 23 comparable transactions to benchmark valuation expectations against
• Health tech startups in Abu Dhabi Global Market and DIFC free zones face a clearer exit map, though no pure-play digital health company has yet tested GCC public markets
• CFOs at mid-size clinic chains with AED 200-500 million in revenue should note that Nomu-style parallel markets are lowering the size threshold for listings
• Private equity sponsors holding healthcare assets acquired between 2020 and 2022 now have a tested public exit path alongside secondary sales

The Department of Health Abu Dhabi (DOH) and the DHA have both accelerated mandatory reporting requirements around financial transparency, clinical outcomes data, and insurance claim standardization. These regulatory moves, while compliance-driven, have the secondary effect of making healthcare companies more audit-ready for public listing.

The pipeline ahead

Analysts tracking the GCC IPO pipeline have identified healthcare and education as the two sectors most likely to increase listing activity in H2 2024 and into 2025. Both sectors are benefiting from population growth, government insurance expansion, and a regulatory environment that favours consolidation over fragmentation.

The UAE's mandatory health insurance frameworks, Daman in Abu Dhabi and the DHA-regulated scheme in Dubai, create predictable revenue streams that public market investors prize. A hospital group with 80% insurance-backed revenue and 10-15% annual patient volume growth is, in capital markets terms, a toll-road asset.

Healthcare CEOs face a timing decision, not a directional one. The investor base has capital to deploy. The 23 companies that listed in H1 2024 proved that. Whether healthcare operators have the governance structures, data infrastructure, and audit readiness to absorb that capital is the remaining variable.